The executive vice president of oncology therapeutics at Gilead Sciences will leave the company to pursue another opportunity, the company announced this week.
Pharmacy
Amid resistance from top shareholders, Bristol-Myers Squibb urged investors in a letter to support its $74 billion deal to acquire cancer drugmaker Celgene, CNBC reports.
A group of protesters stood outside the Massachusetts office of drugmaker Sanofi, demanding more to be done to address the skyrocketing prices of insulin, according to a WBUR news report.
Walgreen's recently launched a first-of-its-kind program in the U.S. designed to help oncology patients and survivors who have undergone physical changes associated with cancer. With the rollout of the "Feel More Like You" program, the company became the first in…
While it is still undecided who will be Dr. Scott Gottlieb's successor when he leaves the FDA in about a month, speculation about several candidates has emerged.
Advertisement
The FDA this week approved a controversial drug to treat depression. While it is a novel antidepressant for people who do not respond to other treatments, it has also raised concerns of potential for its abuse.
CVS Caremark, the pharmacy benefits unit of CVS Health, will shut down a Nashville call center May 3, affecting 250 workers, according to the Nashville Business Journal.
Sen. Mike Braun, R-Ind., unveiled a bill to ban pharmacy rebates in the private market, according to The Washington Examiner.
Eight healthcare organizations — including UnitedHealth Group's OptumRx and Cigna's Pharmacy Management unit — were recognized March 5 by the Pharmacy Benefit Management Institute for their efforts and contributions to pharmacy management.
Consumers could save up to $5,400 a year by price shopping for their medications, according to a new study published by the U.S. Public Interest Research Group.